Cronos Group Reports 2025 Second Quarter Results

Executive Summary

• Cronos Group Inc. reported Q2 2025 financial results, highlighting a 21% year-over-year increase in net revenue to $33.5 million, driven by strong performance in Israel and international markets, as well as the consolidation of Cronos GrowCo.
• The company reported a net loss of $38.5 million for the quarter, a significant increase from the prior year, primarily due to unrealized foreign exchange losses on U.S. dollar-denominated assets held in Canada.
• Cronos maintains a strong balance sheet with $834 million in total cash and cash equivalents and short-term investments, while achieving record revenue for its PEACE NATURALS® brand in Israel and expanding its international footprint.

Key Details

• Financial Performance (Q2 2025):
  • Net Revenue: $33.5 million (up 21% YoY); $65.7 million for the six months ended June 30, 2025 (up 24% YoY).
  • Gross Profit: $14.5 million (up 130% YoY); Gross Margin improved to 43% from 23% in Q2 2024.
  • Adjusted Gross Profit: $14.5 million; Adjusted Gross Margin: 43%.
  • Net Loss: $38.5 million (vs. net loss of $8.8 million in Q2 2024).
  • Adjusted EBITDA: $1.7 million (improved by $12.7 million from Q2 2024's negative $11.1 million).
  • Cash and Cash Equivalents: $794.4 million; Short-term Investments: $40.0 million; Total Liquidity: $834.4 million.
• Revenue Breakdown:
  • Cannabis Flower: $25.0 million (up 21% YoY).
  • Cannabis Extracts: $8.4 million (up 18% YoY).
  • Geographic Split: Canada ($19.2M, -3% YoY), Israel ($9.4M, +36% YoY), Other Countries ($4.9M, +379% YoY).
  • Cronos GrowCo contributed $2.2 million in revenue in Q2 2025 (consolidated since July 1, 2024).
• Operational Updates:
  • Israel: PEACE NATURALS® retained position as #1 cannabis brand in Israel with record revenue and sales volume. New flower strains launched for PEACE NATURALS® and Lit™ brands.
  • Canada: Spinach® brand holds 4.7% overall market share and 4.9% flower market share. Spinach® gummies hold 19.9% market share in edibles. Lord Jones® holds 28.5% market share in hash-infused pre-rolls.
  • International Expansion: PEACE NATURALS® launched in medical cannabis markets in Australia and Malta in Q2 2025, and Switzerland post-quarter-end. Total global markets expanded to seven (Canada, Israel, Germany, UK, Australia, Switzerland, Malta).
  • Cronos GrowCo: Expansion complete; sales from expansion expected in Fall 2025.
  • Regulatory: Israel Ministry of Finance vetoed a proposed 165% anti-dumping duty on Canadian medical cannabis imports, a decision Cronos welcomed.
• Investments:
  • Invested C$25.2 million (approx. $18.5 million USD) in High Tide Inc. (operator of Canna Cabana) via a five-year junior secured convertible loan.
  • Loan Face Value: C$30.0 million (approx. $22.1 million USD) with a 16% original issue discount.
  • Interest Rate: 4% per annum, paid quarterly.
  • Conversion Price: C$4.20 per common share.
  • Warrants: Received a five-year warrant exercisable into up to 3,836,317 common shares at an exercise price of C$3.91 per share.
• Personnel:
  • Appointed Lloyd Wilson as Principal Accounting Officer, effective August 7, 2025.

Notable Quotes

• "Cronos delivered another quarter of strong performance, highlighted by record sales from Cronos Israel and continued momentum in international markets. Our strength abroad has been instrumental in driving meaningful margin improvement, underscoring the benefits of our global strategy." — Mike Gorenstein, Chairman, President and CEO
• "In Canada, despite near-term flower supply constraints, our long-term fundamentals remain robust... Our debt-free balance sheet and $834 million in cash and cash equivalents and short-term investments provide superior flexibility to execute our strategy, expand globally, and deliver value to shareholders." — Mike Gorenstein, Chairman, President and CEO